Asset Management One
TRIB

Asset Management One’s Trinity Biotech TRIB Stock Holding History

Asset Management One’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-527
Closed -$1.04M – 1200
2016
Q3 		$1.04M Sell
527
-15
-3% -$28K 0.02% 835
2016
Q2 		$922K Buy
542
+3
+0.6% +$5.07K 0.01% 870
2016
Q1 		$942K Buy
539
+80
+17% +$127K 0.01% 878
2015
Q4 		$809K Buy
459
+16
+4% +$28.3K 0.01% 932
2015
Q3 		$760K Buy
443
+93
+27% +$224K 0.01% 940
2015
Q2 		$948K Buy
350
+76
+28% +$197K 0.01% 890
2015
Q1 		$791K Buy
274
+183
+201% +$507K 0.01% 959
2014
Q4 		$238K Buy
+91
New +$235K ﹤0.01% 1166
2013
Q3 		– Sell
-31
Closed -$79K – 1128
2013
Q2 		$79K Buy
+31
New +$77.1K ﹤0.01% 1021

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Asset Management One's TRIB Position: Q4 2016 in Review

Asset Management One sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 527 shares — an estimated $1.04M sold.

Asset Management One first reported a position in TRIB in Q2 2013 and held it in 9 quarters. The position peaked at $1.04M in Q3 2016. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • Asset Management One reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 527 Trinity Biotech shares in Q4 2016, an estimated $1.04M.
  • Asset Management One first reported a position in Trinity Biotech in Q2 2013 and held it in 9 quarters.
  • Asset Management One's Trinity Biotech position peaked at $1.04M in Q3 2016.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.